Functional Beer Science
There are two fundamentally different routes to gluten-free beer. Understanding which approach a brewery uses tells you how reliable the claim is — and what the beer will actually taste like.
Published 17 June 2026 · By the JINPAI Brewery production team
Gluten is not a single protein. It is a family of related storage proteins found in certain cereal grains, and the relevant members in brewing are three: hordein from barley, secalin from rye, and gliadin from wheat. All three belong to the prolamin superfamily — proteins rich in the amino acids proline and glutamine — and all three can trigger the immune response in people with celiac disease or non-celiac gluten sensitivity. Barley malt is the backbone of most beer styles, which means hordein is the dominant concern for brewers making gluten-free claims. Wheat beers add gliadin on top of that. Rye is less common but not rare in specialty craft brewing.
The regulatory threshold that defines "gluten-free" in most major markets is below 20 ppm (parts per million) of gluten in the finished product. The EU Regulation 41/2009, the US FDA standard, and Food Standards Australia New Zealand all converge on this number, which derives from clinical research into the dose at which gluten begins to cause intestinal damage in sensitive individuals. Some markets also recognise a second tier: "very low gluten" at below 100 ppm, applicable to beer made from gluten-containing grains that has been processed to reduce gluten — a category that recognises enzyme-treated barley beer in particular. These thresholds are not arbitrary marketing constructs. They represent measurable safety boundaries, and a brewer claiming "gluten-free" needs analytical evidence, batch by batch, that the product crosses that line.
The difficulty is that barley malt is extraordinarily effective at brewing beer. Its enzyme content, fermentability, and flavour contribution are hard to replicate. Any alternative-grain strategy starts with a trade-off against the base ingredient that most beer drinkers have learned to expect. That trade-off is real and it is worth being honest about.
The enzyme route is intellectually elegant. Instead of replacing barley, you destroy the immunoreactive fragment of its gluten proteins while leaving everything else intact. The key enzyme class is prolyl endopeptidase (PEP), sold commercially under the brand name Clarex (DSM) and other formulations. PEP cleaves peptide bonds on the C-terminal side of proline residues — which, given that hordeins are exceptionally proline-rich, means it cuts the gluten proteins into small fragments at exactly the points that matter most for immune reactivity.
The process is added during cold conditioning, typically. Clarex at a dose of around 1–2 g/hL is added to the fermented, cooled beer. At temperatures around 0–4°C and over a contact time of several days, the enzyme works through the residual gluten peptides, breaking the immunoreactive epitopes into fragments too small to be recognised by the antibodies associated with celiac disease. The enzyme itself is a protein derived from a fungal source (Aspergillus niger) and is regarded as a processing aid under most regulatory frameworks — it does not appear on the finished label. After treatment, the beer is filtered and packaged through the standard process.
The grain bill, the mash, the fermentation, the hop profile — none of it changes. The enzyme operates on the finished beer as a targeted intervention, not as a reformulation. This is why enzyme-treated beer can be labelled with identical ABV, colour, and flavour specifications to the non-treated version. The only thing the brewer is modifying is the gluten fraction, and only the immunoreactive portions of that fraction.
There is an important caveat. AN-PEP (aspergillus niger prolyl endopeptidase) and similar enzymes cleave gluten peptides effectively, but the ELISA R5 antibody test — the standard analytical method for measuring gluten in hydrolysed products — may not detect all the peptide fragments that are potentially relevant to celiac disease. Some celiac disease specialists argue that the testing method itself is not fully validated for enzyme-treated beer. This does not mean enzyme-treated beer is unsafe for all coeliacs. It does mean that a below-20-ppm result from ELISA R5 should be understood in context: it confirms the test result, not a guarantee that every celiac individual will tolerate the product without symptoms.
The alternative-grain route avoids gluten at the source. Instead of processing it out of barley, you brew with grains that never contained it. The five most commercially relevant are sorghum, millet, rice, buckwheat, and corn (maize). Each brings a different brewing profile and a different set of process challenges.
The most widely used gluten-free brewing grain globally. Sorghum has its own amylase enzymes and ferments adequately, but its wort is notably different in character — lower in free amino nitrogen (FAN) than barley, which can stress yeast and produce off-flavours if fermentation management is not adjusted accordingly. The flavour profile tends toward dry, slightly tart, with a grain character that is identifiably not barley. Some markets, particularly in Africa where sorghum beer is a cultural norm, accept this profile without hesitation. Export markets expecting a European lager flavour do not.
Millet — specifically finger millet and pearl millet — is gaining ground in craft gluten-free brewing, particularly in North America and Europe. Malted millet has better enzymatic activity than sorghum and produces a wort closer in fermentability to barley malt. The flavour is mild and relatively neutral, making it a better base grain for gluten-free beers trying to stay close to conventional styles. Millet malt is more expensive than sorghum and supply chains are thinner, which constrains its use in high-volume production.
Both are widely used as adjuncts in conventional brewing — most mass-market lagers already contain significant proportions of either. As the sole base grain in a gluten-free formulation they require exogenous enzymes (amylase, glucoamylase) added to the mash to break down their starch, since rice and corn do not malt in the conventional sense and carry minimal intrinsic enzyme activity. The resulting beers tend to be light, clean, and low in body — which suits certain market positions but produces a thin character if body is expected.
Despite the name, buckwheat is not a wheat. It is a pseudocereal — taxonomically unrelated to the grass family — and is naturally free of hordein, gliadin, and secalin. Buckwheat has a distinctive, earthy, slightly nutty flavour that is assertive enough to become the character of a beer rather than its background. It is used in niche and craft contexts, rarely in volume production, but it produces genuinely interesting specialty products and has a strong consumer awareness story in health-conscious markets.
The fundamental advantage of the alternative-grain route is absolute certainty of origin. There is no residual barley in the brew. Cross-contamination aside, the product is intrinsically gluten-free rather than processed into gluten-freedom. For coeliacs who distrust the enzyme treatment debate, this matters. The disadvantage is that the product is genuinely different from conventional beer, and the brewer cannot pretend otherwise.
This is the question most buyers avoid asking directly. Enzyme-treated barley beer and alternative-grain beer are not equivalent products. The gap is real and it affects positioning, consumer expectation management, and ultimately repurchase rate.
Enzyme-treated beer starts from barley malt. The malt sugars, the Maillard-reaction colour compounds, the amino acid pool feeding yeast flavour development — all of it is unchanged. The hops behave the same way. The yeast has the same nutritional environment. The result is a beer that tastes like a beer made from barley, because it is. Sensory panels consistently struggle to distinguish Clarex-treated lager from its untreated equivalent in blind conditions. The body is the same. The carbonation mouthfeel is the same. The hop bitterness is the same. The only change is the absence of immunoreactive gluten peptides.
Alternative-grain beer cannot make that claim. Sorghum brings tartness and a certain metallic edge if fermentation is not managed tightly. Rice produces a clean, almost empty finish — lighter in body than a comparable barley lager. Millet is closer, but the grain character is still distinct to a trained palate. Buckwheat is unmistakable. None of this is a defect — it is a flavour profile, and some consumers actively prefer it. But it is not "the same as regular beer with gluten removed." A buyer positioning a gluten-free alternative-grain product as a direct substitute for a barley lager is setting consumer expectations that the product cannot meet. That creates returns and negative reviews, not loyalty.
The commercial decision comes down to the target consumer. Enzyme-treated: for the celiac or gluten-sensitive drinker who wants beer that tastes like beer. Alternative-grain: for the consumer who is actively choosing a different product, either for medical certainty reasons or because they are drawn to the grain character itself. Both have markets. Neither is universally superior.
The standard analytical method for measuring gluten in food and beverage is the ELISA R5 sandwich assay — developed by Carmen Mendez at the CSIC in Madrid and validated against Codex Alimentarius standards. For intact (unhydrolysed) gluten-containing products it is highly reliable. For hydrolysed products — which enzyme-treated beer is, since brewing fermentation hydrolyses proteins — the standard sandwich ELISA is less reliable because the antibody targets intact peptide sequences that may have been cleaved. The competitive ELISA R5 assay is the recommended variant for hydrolysed samples and is more appropriate for enzyme-treated beer testing. A finished-product result below 5 ppm on a competitive R5 assay gives strong confidence; a result between 5 and 20 ppm warrants retesting.
Cross-contamination is the risk that even alternative-grain breweries cannot ignore in multi-grain production facilities. Barley dust is persistent. Shared milling equipment, shared conveying lines, shared fermenters that were previously used for barley-malt batches — any of these can introduce barley hordein into a nominally gluten-free batch. The practical controls are: dedicated gluten-free production lines or rigorous CIP (clean-in-place) validation between runs; allergen swab testing on equipment before and after changeover; positive airflow and physical separation of ingredient storage; and batch-level testing of the finished product rather than reliance on recipe certification alone.
For a B2B buyer, the right due diligence question is not just "what is your gluten-free process?" but "show me the COA from a certified third-party laboratory for the specific batch I am purchasing." A generic specification or a certificate covering a "reference batch" is not sufficient. The batch you import is the batch that needs the number attached to it. At JINPAI, each gluten-free production run generates its own Certificate of Analysis, with the ELISA result from a third-party laboratory, before that batch ships.
Under most regulatory definitions, yes — if the finished beer tests below 20 ppm by ELISA R5 antibody assay after enzyme treatment, it can be labelled gluten-free in the EU, US, and Australia. The enzyme cleaves the immunoreactive gluten peptide fragments into fragments too small to trigger the immune response. However, celiac disease specialists note that ELISA R5 may not detect all peptides relevant to celiac disease, and some coeliacs choose to avoid enzyme-treated barley beer regardless of the test result.
Alternative-grain gluten-free beers (sorghum, rice, millet) taste noticeably different from barley-malt beer: thinner body, different grain character, sometimes slightly tart or starchy. Enzyme-treated barley beer tastes much closer to conventional beer because the base grain bill is unchanged; only the gluten fraction is modified. For most casual drinkers, enzyme-treated versions are indistinguishable from conventional equivalents.
Yes. JINPAI has enzyme-addition capability in our fermentation process and can produce batches with measured gluten content below 20 ppm. Each gluten-free production run is tested by third-party laboratory and results included in the Certificate of Analysis. Contact our technical team for recipe development and production capacity information.
